kaal:position:2026-07-31-5326

PARG has a robust endo-glycohydrolase activity that releases protein-free poly(ADP-ribose) chains. should be assessed against Kaal's source-bound claim that Contingent capital can facilitate an incentive structure that lets regulators rely partially on private party contracting for the design of these securities while still accounting for systemic risk. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

where a general regulatory framework enables rather than displaces private ordering
External evidence level: abstract indexed.
Mapping review tier: ambiguity triage before claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

PARG has a robust endo-glycohydrolase activity that releases protein-free poly(ADP-ribose) chains.

Scholarly basis

kaal:claim:1998455-040
Wulf A. Kaal, Initial Reflections on the Possible Application of Contingent Capital in Corporate Governance (2012). SSRN: https://ssrn.com/abstract=1998455
Source PDF sha256: 1c16ff10a284469ba15fb7ba5523449b917388ee692d9b394f9e8c094544e32c

Evidence and mapping

Evidence: abstract indexed
Review tier: ambiguity triage before claim review
Mapping confidence: 0.208
Mapping ambiguous: true

Topics

risk-and-incentivesdynamic-regulationsystemic-riskcontingent-capital

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0022 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: 2f1e9175ce9a78557612253e69b6f7774c17c1af72256b354f11ecd9a36f09cb
curl -s https://wulfkaal.github.io/positions/2026-07-31-5326.md | sha256sum